Abstract Background: Patellar Clunk
Introduction
A diverse set of complications is attributed to the patella following total knee arthroplasty (TKA). These complications may include malposition of the patellar component and dynamic problems such as recurrent subluxation or disruption of the extensor mechanism [11] . Focal scarring at the upper patella pole may cause a locking sensation or impaired motion during movement of the knee [4] .
The term patellar clunk syndrome was introduced 1989 in a case report by Hozack et al. [4] . A prominent fibrous nodule was described to be found at the junction of the proximal patellar pole and the quadriceps tendon in some cases after posterior stabilized TKA. This nodule enters the intercondylar notch with flexion and displaces with an audible and often painful clunk with extension. Cases identifying the phenomenon of suprapatellar fibrous tissue getting caught on extension were reported earlier by Insall and Simison without giving causation of the possible mechanism [3, 5, 6, 12] . Beight et al. [1] described the patellar clunk syndrome in a number of cases following the first generation of posterior stabilized TKA, which possessed a sharp edge at the superior edge of the intercondylar notch. A possible explanation was postsurgical scar formation leading to development of a clunk at a mean of 10.6 months after surgery. Arthroscopic resection of this hypertrophic nodule was described to be highly successful when compared to an open approach [14] .
While the diagnosis is largely based on clinical examination, radiographic abnormities associated with patellar clunk syndrome include patella baja, a proximally placed patellar button or a subluxing or frankly dislocated patellar component. Conventional radiographs are limited in defining the soft tissue lesion. Due to its multiplanar capabilities and superior soft tissue contrast, MRI is the method of choice for the evaluation of native joints. Traditional MRI of TKA is limited due to artifact generated by the metallic components. Recent modifications in protocols have shown MRI to be helpful in the evaluation of painful joints, including total hip and knee arthroplasty [9] . As such, MRI could be a key diagnostic tool to evaluate patellar clunk syndrome after total knee replacement closing the large gap between clinical findings and conventional radiographic assessment.
It was hypothesized that MRI would prove helpful and reproducible in confirming the clinical diagnosis of patellar clunk by visualizing the soft tissues proximal to the patella. The specific aims for this study were to (1) demonstrate that MRI can identify and characterize the lesion causing the patellar clunk syndrome following TKR; (2) to show that the dimensions of the lesion can be reproducibly measured, and that (3) the information obtained from the MRI can support the decision to proceed with arthroscopic debridement as treatment for the patellar clunk syndrome.
Material and Methods
In this retrospective case series, MRI scans performed in 12 patients with the clinical suspect or related symptoms of a patellar clunk syndrome after primary TKA were evaluated followed by a chart review. Descriptive variables were recorded including patient demographics, clinical signs of patellar clunk, and revision or arthroscopic surgery, if performed.
The cohort included five women and seven men with a clinically suspected diagnosis of patellar clunk with an average age of 63.4±8.8 years at index TKA (four left, eight right knees). All patients underwent TKA for degenerative joint disease. MRI was done at a mean interval of 16.2±8.0 months after index procedure.
All TKAs were posterior stabilized with a Zirconium femoral component (Oxinium, Smith and Nephew, Memphis, TN, USA) in one case, and conventional components of cobalt/chrome/molybdenum alloy (CoCrMo) in 11 cases. The corresponding tibial components were modular with a PE insert in a titanium/aluminium/vanadium alloy base plate (TiAlV).
To reduce artifacts caused by the metallic implant, it is necessary to modify the pulse sequence parameters. Magnetic resonance imaging scans were acquired with a 1.5-Tesla superconducting magnet (HDx; GE Medical Systems, Milwaukee, WI, USA). The patients were imaged using a standard phased-array extremity coil (phased-array extremity coil, Med Rad, Indianola, PA, USA). Sagittal inversion recovery images were obtained with an inversion time of 150 ms, a repetition time (TR) of 4,000 to 5000 ms, an echo time (TE) of 17 ms (4,000-5000/17), a 256-224 matrix, a 20-to 22-cm field of view, 4-mm thick sections with no intersection gap, and two excitations. The receiver bandwidth was 32 kHz. Sagittal fast spin echo images were obtained with a TR/TE of 4,000 to 5,000/34, 12-to 18-echo train length, 3.5-mm slice thickness with no interslice gap, 62.5-83-kHz bandwidth (over the entire frequency domain), 512-288 matrix, 18-cm field of view, 4 to 5 excitations. Axial and coronal fast spin echo images were obtained with similar parameters but with a field of view of 16 cm and slice thickness of 3 mm with no interslice gap.
The size of the abnormal soft tissue lesion proximal to the patella was determined in sagittal and axial MRI views. The nodule tissue was characteristically of intermediate signal intensity on the moderate echo time pulse sequence, characteristic of synovial scarring. There were no MR features to suggest a hemorrhagic content. Largest diameters were recorded in two dimensions by two independent observers who had not been involved in treatment of patients.
Continuous variables were shown as mean and SD. Categorical data were given in absolute figures. For analysis of data, p<0.05 was considered as statistically significant. After verifying equal distribution, values were analyzed by Student's t test. The mean values of the results by two independent investigators (L.C. and T. H.) were used as basis for assessment of interobserver reliability by intraclass correlation coefficients (ICC). They were calculated by two-way random effects analysis of variance with random observers (ICC (2,1) ). Values >0.75 are considered as significant for a reproducible interobserver reliability. Statistical analysis was supported by using Microsoft Excel (Microsoft Corporation, Seattle, USA) and IBM SPSS Statistics 18 (PASW 18, SPSS Inc., Chicago, IL, USA).
Results
MRI can predictably identify the soft tissue lesion associated with patellar clunk syndrome. Nine patients showed obvious MRI findings attributable to a patellar clunk lesion (75%). In all cases, these were intra-articular soft tissue masses proximal to the patella. In two patients, MRI did not show any signs of abnormal soft tissue. In one patient, artifact caused by the femoral CoCrMo component precluded evaluation of the extensor mechanism.
The dimensions of the lesion causing the soft tissue nodule can be reproducibly measured from MRI scans. In the sagittal plane (Fig. 1) , mean diameters of the nodule were 6.7±2.1 mm (observer 1) and 7.4±1.7 (observer 2, p=0.22, ICC 0.76) for the anteroposterior dimension and 17.3±7.1 (observer 1) and 17.6±8.6 (observer 2, p=0.77, ICC 0.892) for the proximodistal dimension. Artifact interfered with evaluation in two patients on sagittal images. In the axial plane (Fig. 2) , mean diameters of the nodule were 9.5±1.7 (observer 1) and 10.0± 2.4 mm (observer 2, p=0.39, ICC=0.755) for the anteroposterior dimension and 33.1±7.9 (observer 1) and 32.2± 9.5 mm (observer 2, p=0.53, ICC=0.929) for the transverse dimension. In one patient, artifact generated by the femoral component prevented evaluation of the extensor mechanism in the axial view. MRI provides supportive evidence helpful in making the decision to treat the patellar clunk symptoms by arthroscopic debridement. Eight of the nine patients with an MRI confirmed clinical diagnosis had an arthroscopic debridement. One patient accepted the diagnosis and refused surgery. In the three patients without MRI findings, no surgery was performed, and the patients were managed conservatively.
Discussion
MRI is helpful and highly reproducible in confirming the clinical diagnosis of patellar clunk. The reproducibility of the MRI findings and determination of the size of patellar clunk leison could be detected and measured with high interobserver reliability. The information obtained from the MRI supported the decision to proceed with arthroscopic debridement in eight of the twelve patients in this series.
This study has some limitations mainly due to its retrospective design and to the small group size of this rare entity following posterior stabilized TKA. Raphael et al. [10] demonstrated improved visualization and higher interobserver agreement in MRI evaluation of zirconium knee implants compared to CoCrMo components. In the presented data, more artifacts were seen around CoCrMo femoral components. In one case, artifact precluded evaluation of the extensor mechanism. In ten cases, the soft tissues proximal to the patella could be successfully visualized despite a CoCrMo component (91%). MRI confirmed patellar clunk at a mean interval of 16 months after TKA. Patellar clunk has been described to occur relatively early after TKA in another series, at a mean of 10.6 months [1] .
Modified MRI protocols reduce metal artifact, allowing for visualization of ligaments, tendons, and the implantbone interface, and these protocols are available using most 1.5 T commercial MRI units [13] . A number of applications for MRI after TKA have been described [2, [7] [8] [9] 15] .
In conclusion, the presented cases indicate that MRI is effective in the confirmation of clinically evident patellar clunk after TKA by directly visualizing the intra-articular soft tissue proliferation proximal to the patella, thereby directing appropriate management. MRI is a powerful tool for assessment of a painful TKA. Indications for MRI following TKA are still being established and the advent of new pulse sequences and technical refinements will further our understanding of the utility of advanced imaging following arthroplasty. Future works will have to focus on establishing diagnostic evaluation algorithms.
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